CURI (CURI)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$131.54M
EV / Sales1.83
EV / EBITDA19.53
EV / Operating Cash Flow10.66
EV / Free Cash Flow10.68

Return Metrics (TTM)

Return on Equity (ROE)-18.46%
Return on Assets (ROA)-11.68%
Return on Invested Capital (ROIC)-21.88%
Return on Capital Employed (ROCE)-22.12%

Yield Metrics

Earnings Yield-5.61%
Free Cash Flow Yield8.52%

Balance Sheet Strength

Net Debt / EBITDA-1.95
Current Ratio0.95
Working Capital-$1.32M
Tangible Asset Value$36.46M
Net Current Asset Value-$5.23M

Working Capital Efficiency

Days Sales Outstanding29.56
Days Payables Outstanding76.29
Operating Cycle (Days)29.56
Cash Conversion Cycle-46.73

Capital Allocation

CapEx / Revenue0.03%
CapEx / Operating Cash Flow0.20%
R&D / Revenue0.00%
SG&A / Revenue69.66%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin56.58%
Operating Margin-10.19%
Net Profit Margin-8.97%

Solvency

Debt / Equity0.09
Quick Ratio1.23
Cash Ratio0.60

Per Share

Revenue / Share$1.24
FCF / Share$0.22
PE Ratio-34.55